INTERNATIONAL STEM CELL CORPORATION— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$2M
↓-11.9% -$291Kvs FY2024 (Q4)
Gross Profit
$1M
↓-25.2% -$367Kvs FY2024 (Q4)
Operating Income
$858K
↑+3800.0% +$836Kvs FY2024 (Q4)
Net Income
$823K
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $2M | $2M |
| COGS | $1M | $990K |
| Gross Profit | $1M | $1M |
| R&D | $177K | $210K |
| SG&A | $0 | $0 |
| D&A | $54K | $54K |
| Other OpEx | $0 | $1M |
| Operating Income | $858K | $22K |
| Interest Exp. | $35K | $22K |
| Other Non-Op | $0 | $0 |
| Pretax Income | $823K | $0 |
| Tax | $0 | $0 |
| Net Income | $823K | $0 |
QuarterCharts · SEC EDGAR data · ISCO · Comparing FY2025 (Q4) vs FY2024 (Q4)